Nektar's new NKTR-102 Phase 2 data in metastatic breast cancer to be presented at 33r
Nektar Therapeutics today announced that new Phase 2 clinical data from its study of single-agent NKTR-102 in metastatic breast cancer patients will be presented at the 33rd Annual CTRC-AACR San Antonio Breast Cancer Symposium (SABCS) in San Antonio, Texas on December 12, 2010.
More... |
All times are GMT -7. The time now is 12:37 AM. |
Powered by vBulletin® Version 3.8.7
Copyright ©2000 - 2024, vBulletin Solutions, Inc.
Copyright HER2 Support Group 2007 - 2021